Wellbutrin XL
Showing 1 - 25 of 167
Meniere Disease, Ménière's Vertigo, Vertigo, Intermittent Trial in Amherst (Lamotrigine and Bupropion, Placebo)
Recruiting
- Meniere Disease
- +3 more
- Lamotrigine and Bupropion
- Placebo
-
Amherst, New YorkDent Neurologic Institute
Jun 17, 2022
MDD Trial in Nashville (Escitalopram, Bupropion XL)
Completed
- Major Depressive Disorder
- Escitalopram
- Bupropion XL
-
Nashville, TennesseeVanderbilt Psychiatric Hospital
Aug 25, 2021
Smoking Cessation, Cancer, Treatment-Related Trial in Lexington (drug, behavioral, other)
Recruiting
- Smoking Cessation
- Cancer, Treatment-Related
- Varenicline
- +6 more
-
Lexington, KentuckyUniversity Of Kentucky, Markey Cancer Center
Feb 9, 2022
Bipolar I Disorder Trial in Vancouver (Escitalopram, Wellbutrin XL)
Completed
- Bipolar I Disorder
- Escitalopram
- Wellbutrin XL
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Jul 9, 2021
Lung Non-Small Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Philadelphia (Nicotine Replacement, Bupropion
Recruiting
- Lung Non-Small Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Nicotine Replacement
- +6 more
-
Philadelphia, Pennsylvania
- +1 more
Aug 31, 2021
Cigarette Smoking-Related Carcinoma Trial in Houston (Bupropion Hydrochloride Controlled-release, Nicotine Replacement,
Unknown status
- Cigarette Smoking-Related Carcinoma
- Bupropion Hydrochloride Controlled-release
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2020
Methamphetamine Use Disorder Trial in United States (Naltrexone: Vivitrol®, Placebo (PLB) Injectable, Bupropion: Wellbutrin XL®)
Completed
- Methamphetamine Use Disorder
- Naltrexone: Vivitrol®
- +3 more
-
Los Angeles, California
- +7 more
Apr 6, 2021
MDD Trial in Saint Louis (Bupropion XL 300)
Completed
- Major Depressive Disorder
- Bupropion XL 300
-
Saint Louis, MissouriWashington University School of Medicine
Apr 23, 2020
Stimulant Use, Relapse, Cognitive Function Trial in Los Angeles (Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion)
Not yet recruiting
- Stimulant Use
- +3 more
- Contrave 8Mg-90Mg Extended-Release Tablet
- Bupropion
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Aug 31, 2022
Substance Abuse, Cocaine Dependence Trial in Baltimore (Placebo, Bupropion XL, Abstinence Initiation)
Completed
- Substance Abuse
- Cocaine Dependence
- Placebo
- +3 more
-
Baltimore, Maryland
- +1 more
Aug 24, 2021
Depression Trial in New York (Paroxetine, Bupropion)
Terminated
- Depression
-
New York, New YorkColumbia University/New York State Psychiatric Institute
Oct 3, 2018
Nifedipine Dosing Daily vs TwiceDay for Pre-eclampsia With
Recruiting
- Preeclampsia With Severe Features
- Nifedipine XL
-
Columbus, OhioThe Ohio State University Wexner Medical Center OB/GYN Maternal
Sep 20, 2022
Trichomonal Vaginitis, Bacterial Vaginosis, Candidal Vulvovaginitis Trial in Izmir (EVEGYN A, EVEGYN B, Gynomax® XL Vaginal
Completed
- Trichomonal Vaginitis
- +3 more
- EVEGYN A
- +2 more
-
Izmir, TurkeyEge University Family Planning and Infertility Application and R
Sep 25, 2023
Skin Hydration in Healthy Volunteers Trial in Northfield (Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™
Completed
- Skin Hydration in Healthy Volunteers
- Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant
-
Northfield, IllinoisMedline Industries, LP
Feb 23, 2023
Aortic Stenosis Trial in Camperdown, Brisbane, Clayton (ACURATE Prime XL Transfemoral Aortic Valve System)
Active, not recruiting
- Aortic Stenosis
- ACURATE Prime XL Transfemoral Aortic Valve System
-
Camperdown, New South Wales, Australia
- +2 more
Oct 25, 2022
Subject Understanding of ZYBAN/ WELLBUTRIN Associated Risks
Completed
- Depressive Disorder, Major
- KAB survey
- (no location specified)
Feb 9, 2018
Methamphetamine Use Disorder Trial in Los Angeles, Honolulu, Dallas (naltrexone plus bupropion)
Completed
- Methamphetamine Use Disorder
- naltrexone plus bupropion
-
Los Angeles, California
- +2 more
Mar 9, 2020
DermaClose DUKE Fasciotomy and Wound Study
Recruiting
- Wound of Skin
- DermaClose Continuous External Tissue Expander Device
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Dec 29, 2022
Actinic Keratosis, Keratosis, Actinic, Keratosis Trial in United States (BF-200 ALA and red light LED lamp)
Recruiting
- Actinic Keratosis
- +2 more
- BF-200 ALA and red light LED lamp
-
Phoenix, Arizona
- +8 more
Jan 12, 2023
High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)
Recruiting
- High Grade Serous Carcinoma
- +2 more
- Olaparib tablet
- Navitoclax
-
Toronto, Ontario, Canada
- +2 more
Nov 28, 2022
Third Molar Extraction Trial in São Paulo (FDC of etoricoxib + cyclobenzaprine + etoricoxib , etoricoxib 90 mg (Arcoxia®) +FDC ,
Not yet recruiting
- Third Molar Extraction
- FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo
- +2 more
-
São Paulo, SP, BrazilEurofarma Laboratorios S.A
Jan 11, 2023
Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer Trial (Stereotactic Body Radiotherapy, Microwave Ablation)
Recruiting
- Colorectal Cancer Metastatic
- Liver Metastasis Colon Cancer
- Stereotactic Body Radiotherapy
- Microwave Ablation
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC
Dec 18, 2022
Obesity, Morbid, Liver Fibrosis Trial in Paris (For the first 60 patients: 3 XXL probe prototypes of the FibroScan 630 Research
Completed
- Obesity, Morbid
- Liver Fibrosis
- For the first 60 patients: 3 XXL probe prototypes of the FibroScan 630 Research Model
- From patient 61 to patient 120: 1 XXL probe prototype of the FibroScan 630 Research Model
-
Paris, FranceHôpital la Pitié Salpêtrière
Aug 5, 2022